Highly Parallel SNP Genotyping
- J.-B. FAN,
- A. OLIPHANT,
- R. SHEN,
- B.G. KERMANI,
- F. GARCIA,
- K.L. GUNDERSON,
- M. HANSEN,
- F. STEEMERS,
- S.L. BUTLER,
- P. DELOUKAS,
- L. GALVER,
- S. HUNT,
- C. MCBRIDE,
- M. BIBIKOVA,
- T. RUBANO,
- J. CHEN,
- E. WICKHAM,
- D. DOUCET,
- W. CHANG,
- D. CAMPBELL,
- B. ZHANG,
- S. KRUGLYAK,
- D. BENTLEY,
- J. HAAS,
- P. RIGAULT,
- L. ZHOU,
- J. STUELPNAGEL, and
- M.S. CHEE
This extract was created in the absence of an abstract.
Excerpt
The genetic factors underlying common disease arelargely unknown. Discovery of disease-causing genes willtransform our knowledge of the genetic contribution tohuman disease, lead to new genetic screens, and underpinresearch into new cures and improved lifestyles. The sequencing of the human genome has catalyzed efforts tosearch for disease genes by the strategy of associating sequence variants with measurable phenotypes. In particular, the Human Genome Project and follow-on efforts tocharacterize genetic variation have resulted in the discovery of millions of single-nucleotide polymorphisms(SNPs) (Patil et al. 2001; Sachidanandam et al. 2001;Reich et al. 2003). This represents a significant fraction ofcommon genetic variation in the human genome and creates an unprecedented opportunity to associate genes withphenotypes via large-scale SNP genotyping studies...
